Cat. No. 3828
Alternative Name: CGP 33101
Chemical Name: 1-[(2,6-Difluorophenyl)methyl]-1H-1
Biological ActivityBoard spectrum anticonvulsant. Prolongs the inactivation of sodium channels and limits the frequency of action potential firing in cultured and acutely isolated neurons. Displays anticonvulsive activity in a range of animal seizure models.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
White et al (2008) The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models. Epilepsia 49 1213. PMID: 18325020.
Arroyo (2007) Rufinamide. Neurotherapeutics 4 155. PMID: 17199032.
Rogawski et al (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res. 69 273. PMID: 16621450.
If you know of a relevant reference for Rufinamide please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Rufinamide from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Rufinamide, supplier, CGP33101, sodium, channels, voltage-gated, voltage-dependent, NaV, Na+, prolongs, inactivation, anticonvulsant, anticonvulsive, antiepileptic, Tocris Bioscience, Voltage-gated Sodium (NaV) Channel products